Skip to content

Opko Health OPK Current ratio

Current ratio at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
1.2×-0.3×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
10.9×-4.3×
HRO
HarrowHROW
2.5×+1.6×
Precigen logo
PrecigenPGEN
4.8×+1.3×
Immunome logo
ImmunomeIMNM
21.7×+11.2×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-0.4×

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on the most recent quarter.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's current ratio?
Opko Health (OPK) reported current ratio of 3.6× in Q1 2026.
How has Opko Health's current ratio changed year-over-year?
Opko Health's current ratio increased by 44.7% year-over-year, from 2.5× to 3.6×.
What is the long-term trend for Opko Health's current ratio?
Over 5 years (2020 to 2025), Opko Health's current ratio has grown at a 23.3% compound annual growth rate (CAGR), from 1.4× to 4×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.